X
API Suppliers
US DMFs Filed
CEP/COS Certifications
JDMFs Filed
Other Certificates
Other Suppliers
0
USA (Orange Book)
Europe
Canada
Australia
0
South Africa
0
Uploaded Dossiers
U.S. Medicaid
Annual Reports
https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=216726
https://www.pharmacompass.com/pdf/news/enforcement-report-week-of-october-25-2023-66768.pdf
https://www.fda.gov/safety/recalls-market-withdrawals-safety-alerts/vistapharm-llc-issues-voluntary-nationwide-recall-sucralfate-oral-suspension-1g10ml-due-microbial
https://www.pharmacompass.com/pdf/news/enforcement-report-week-of-september-20-2023-9936.pdf
https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=215705
https://www.businesstoday.in/latest/story/national-list-of-essential-medicines-nlem-2022-govt-adds-34-new-drugs-four-anti-cancer-medicines-347146-2022-09-13
https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=212913
https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=212913
https://www.pharmacompass.com/pdf/news/enforcement-report-week-of-april-13-2022-1649826529.pdf
https://www.fiercepharma.com/pharma/hailing-paradigm-shift-clayton-gets-fda-oral-suspension-ok-challenge-abbvie
https://www.prnewswire.com/news-releases/clayton-pharmaceuticals-and-vistapharm-a-vertice-company-receive-fda-approval-for-sucralfate-oral-suspension-301519845.html
https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=211884
https://www.prnewswire.com/news-releases/endo-begins-shipment-of-authorized-generic-version-of-carafate-sucralfate-oral-suspension-in-the-united-states-300993846.html
https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=209356
https://www.biospectrumasia.com/news/25/13161/chugai-pharma-sells-ulcerlmin-business-to-fuji-chemical-.html
Market Place
Share 
